Latest chronic pain Stories
Researchers in France and Sweden have discovered how one of the body's own proteins is involved in generating chronic pain in rats. The results, which also suggest therapeutic interventions to alleviate long-lasting pain, are reported in The EMBO Journal. Chronic pain is persistent and often difficult to treat. It is due, at least in part, to changes in molecular signalling events that take place in neurons, alterations that can ultimately disrupt the transmission of nerve signals from the...
Fifth Annual Awards Competition Dedicated to Independent Pain Research KIRKLAND, QC, June 12, 2012 /CNW/ - Pfizer Canada is pleased to announce the recipients of the 2011 Neuropathic Pain Research Awards, an annual grant competition for independent research in the areas of basic biomedical, clinical and health service and systems sciences.(1) "For the past five years, the Neuropathic Pain Research Awards have supported Canadian medical innovation and research in neuropathic...
SHELTON, Conn., June 11, 2012 /PRNewswire/ -- Cara Therapeutics, Inc. today announced positive results from a Phase II study for the treatment of acute post-operative pain with its novel, peptide-based, peripherally-acting kappa opioid agonist, CR845. The study successfully met its primary endpoint which measured the effect of CR845 treatment on reducing the amount of rescue opioid analgesics used in the 24 hour period post-surgery, as well as secondary endpoints which...
SAN FRANCISCO, June 7, 2012 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) announced today that the U.S. Food and Drug Administration (FDA) has designated NKTR-181 as a Fast Track development program for the treatment of moderate to severe chronic pain. NKTR-181 is a novel mu-opioid agonist molecule, which is designed to have a slow rate of entry into the brain to reduce the attractiveness of the molecule as a target of abuse and to reduce its CNS-mediated side effects. NKTR-181...
DANVERS, Mass. and BEVERLY, Mass., June 4, 2012 /PRNewswire/ -- Pain affects nearly everyone at some point in their lives, and, in the worst cases, diminishes quality of life and livelihood. In fact, pain is a significant health problem affecting more than 100 million people and costing society at least $560-$635 billion annually in both health care and lost productivity costs.* Now research shows that pain patients do better with a comprehensive approach to care that addresses the...
STAMFORD, Conn., June 4, 2012 /PRNewswire/ -- Purdue Pharma L.P. will present data evaluating physician understanding of the Risk Evaluation and Mitigation Strategy (or REMS) for Butrans® (buprenorphine) Transdermal System CIII at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual International Meeting. The data includes results from a post-test evaluation of prescribers who completed Butrans REMS training between December 2010 and February...
LOS ANGELES, June 4, 2012 /PRNewswire/ -- Chronic aches and pains can stem from a variety of sources, whether it's a car accident or other injury, an invasive medical procedure, the onset of arthritis or other diseases, or even an entirely unknown cause. In the fight to retain a comfortable lifestyle and remain mobile, many people find themselves struggling through courses of drugs and difficult physical therapy sessions - only to realize little to no improvement. When traditional...
RALEIGH, N.C., May 31, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Jefferies 2012 Global Healthcare Conference in New York City. The presentation is scheduled for Thursday, June 7 at 3:30 P.M. Eastern Time. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo will focus on the clinical development program and timeline for...
SCHAUMBURG, Ill., May 31, 2012 /PRNewswire/ -- Wellness Center USA, Inc. (OTCQB/OTCBB: WCUI), a Schaumburg IL based healthcare and nutraceutical company, today announced the signing of an agreement to acquire CNS Wellness, LLC (CNS), a Tampa, FL based cognitive neuroscience corporation specializing in the treatment of brain-based behavioral health disorders including developmental, emotional and stress-related problems. CNS's drug free and non-invasive methods provide...
LOS ANGELES, May 29, 2012 /PRNewswire/ -- Floating weightlessly in a pool of warm, relaxing water, Watsu® clients release tension and enjoy the sensation of broad and graceful guided gestures as a trained professional gently keeps their eyes and noses above the water and facilitates healing movements. Through the delivery of therapeutic touch and pin-pointed twists and stretches, the Watsu® practitioner helps clients overcome common problems ranging from arthritic pain to anxiety...
